Investigation and Management of Community-Acquired Pneumonia (CAP) Frequently Asked Questions
|
|
- Tracey Banks
- 5 years ago
- Views:
Transcription
1 Investigation and Management of Community-Acquired Pneumonia (CAP) Frequently Asked Questions 1. Why was this algorithm developed? Emergency department physicians were seeking guidance about best antimicrobial therapy for common infectious diseases in light of increasing interest around issues of antimicrobial stewardship, emergency department efficiency, and patient safety. What started as a local initiative grew into a Toronto Central LHIN-wide initiative in an effort to improve the impact of such efforts. 2. How was this algorithm developed? A small working group, comprised of two emergency medicine physicians, an infectious diseases physician, and an infectious diseases pharmacist met and created an initial draft after reviewing the relevant literature (including published national/international clinical practice guidelines 1-4 ), obtaining current local microbiology data, consulting with experts in infection prevention and control, and considering the practices of emergency room medicine in the Toronto Central LHIN. The draft algorithm was sent for broad stakeholder consultation, and numerous changes were made based on stakeholder feedback. A consensus meeting was convened, involving key opinion leaders from the areas of critical care medicine, emergency medicine, general internal medicine, infectious diseases, pharmacy, and respirology, with representation from all of the hospitals in the Toronto Central LHIN. Further modifications to the algorithm were made, and the document was once again sent for stakeholder feedback. The algorithm was also tested for ease-of-use and clarity by experts in Human Factors engineering. 3. Why did you choose to use CRB-65 for severity? I am much more familiar with PSI or CURB-65. CURB-65 uses Urea in its measurement. Several TC LHIN hospitals no longer use (or are considering discontinuing availability of) urea in routine bloodwork. The PSI (Pneumonia Severity Index) is a high-quality, wellvalidated score for pneumonia. 5 Although it provides good prognostic information, the emergency room physicians who are most likely to make frequent use of a severity tool were fairly unanimous that the time required to complete it makes it prohibitive. As such, we chose CRB-65, a tool that has been validated in 14 studies, involving almost patients. 6 Additionally, we are encouraging physicians to use CRB-65 only as an adjunct to clinical judgment. 4. What other investigations should routinely be performed for most patients with suspected CAP?
2 There is little evidence guiding which investigations should be performed in CAP. Most patients admitted to hospital will have received routine bloodwork in the emergency department (CBC, electrolytes, creatinine, glucose). Urinalysis +/- urine culture, blood gas testing, d-dimer testing (and other tests for investigating pulmonary embolism) can all be considered when the diagnosis of CAP is uncertain. Patients initially diagnosed with CAP in the emergency department frequently have other diagnoses recognized following admission 7 the most common of these are outlined in the algorithm. 5. What routine microbiologic investigations should be performed in the emergency department? Most patients do not require microbiologic testing. Serology for Mycoplasma and Chlamydophila species has poor operating characteristics. The Ontario Public Health Laboratories are able to perform PCR for these species (using nasopharyngeal swab specimens, similar to influenza), but these are not routinely recommended in most patients. Urine testing for Legionella antigen, which remains positive for weeks, has an expected overall sensitivity of approximately 64-99%, with a specificity of ~99%. It has a lab turnaround time of 1 day (but is tested at the Provincial Health Laboratory, so realistic turnaround may be up to 3 days). The working group advocates testing for those patients who have failed to respond to an initial course of β-lactam therapy and for those with severe cases of CAP (included in the algorithm). PCR for Legionella can be performed on lower respiratory samples such as bronchoalveolar lavage (BAL), or sputum (if BAL is unavailable). Blood cultures are not routinely advocated for CAP. Approximately 7% of patients with CAP will have positive blood cultures, most of who will grow S. pneumoniae or H. influenzae (and are unlikely to have results of blood cultures alter therapy). However, patients with CAP meeting SIRS criteria have a much higher likelihood of having positive blood cultures, and should have blood cultures drawn. 8 SIRS Criteria At least 2 of the following: Temperature <36 C or >38 C Heart rate >90/min Respiratory rate >22/min OR pco2 >32 mm Hg on arterial blood gas White blood cell count <4000/µL or >12 000/µL (or >10% immature/band neutrophils)
3 6. The most obvious difference between this algorithm and many published guidelines (including that of the Infectious Diseases Society of America 2,3 ) relates to the de-emphasis of therapy for atypical bacteria (i.e. Chlamydophila pneumoniae, Legionella species and Mycoplasma pneumoniae). Why was this done? The issue of atypical coverage is a contentious one. 9 Many guidelines have chosen to include atypical coverage for all clinical scenarios of CAP (including the Canadian Thoracic Society, the Infectious Diseases Society of America/American Thoracic Society, and the British Thoracic Society) 2,3,10 although the most recent Dutch Guidelines do not 4. The recent European Guidelines indicate that 'definite conclusions cannot be made from the present data. Therefore, it appears that combination treatment should be restricted to patients with higher risk classes'. 11 The authors of the various guidelines advocating atypical coverage have used several lines of reasoning to support their recommendations, including the evidence from large-scale studies demonstrating the importance of atypical bacteria in the epidemiology of CAP. Additionally, a widely cited retrospective health services research study looking at almost elderly (US Medicare) patients with CAP found that initial combination therapy with a cephalosporin and macrolide or fluoroquinolone monotherapy were associated with lower 30-day mortality compared to either β-lactam or macrolide monotherapy. 12 However, there are no large-scale, high-quality, randomized controlled trials demonstrating the superiority of therapy that includes coverage for atypical bacteria over therapy that does not. To the contrary, 3 peer-reviewed published systematic reviews for patients with CAP managed as either inpatients or as outpatients, involving dozens of trials and thousands of patients have failed to demonstrate superiority of adding coverage of atypical bacteria in treatment regimens In addition, no single trial has ever demonstrated superiority of one regimen versus another. In the province of Ontario, approximately patients are diagnosed with Legionnaire s Disease (i.e. Legionella pneumonia) annually. 16 Clustering of cases occurs between June and October. Legionella is rare in winter months. In recent years, the number of diagnoses has increased, although it is unclear whether this is due to a high incidence of Legionellosis or due to increased testing. Mortality from Legionnaire s disease in Ontario is 9%. On the basis of this information, combined with concerns of cost (to patients and to society), resistance (esp. to fluoroquinolones), and C. difficile, 17 the Toronto Central LHIN CAP Working Group chose to de-emphasize therapy for atypical bacteria.
4 7. Why not use macrolide monotherapy for outpatients? It covers the atypicals AND S. pneumoniae. The driving reason to remove macrolides as first-line therapy in outpatient CAP relates to increasing pneumococcal resistance to macrolides, which was 28% in Ontario in (courtesy of Dr. Allison McGeer, personal communication). For this same reason, amoxicillin is not included as empiric therapy because of the significant resistance (~20%) found in H. influenzae isolates. Concerns about the safety of azithromycin 18 are notable, but the Working Group felt the magnitude of the issue was secondary compared to resistance issues. 8. Does this algorithm really apply to Nursing Home patients? I thought they are more at risk for drug-resistant infections. There is no strong evidence that nursing home pneumonia should be treated differently than community-acquired pneumonia. Several recent studies have demonstrated that the bacterial pathogens are largely similar in the two demographic groups, and that the same treatment approaches can be used for the two groups References 1 Hedlund, J., Strålin, K., Örtqvist, Å., Holmberg, H. & The Community-Acquired Pneumonia, W. O. Swedish guidelines for the management of communityacquired pneumonia in immunocompetent adults. Scandinavian Journal of Infectious Diseases 37, , doi: / (2005). 2 Mandell, L. A. et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44 Suppl 2, S27-72, doi: / (2007). 3 Lim, W. S. et al. BTS guidelines for the management of community acquired pneumonia in adults: update Thorax 64 Suppl 3, iii1-55, doi:64/suppl_3/iii1 [pii] /thx (2009). 4 Wiersinga, W. J. et al. SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults. The Netherlands journal of medicine 70, (2012). 5 Fine, M. J. et al. A prediction rule to identify low-risk patients with communityacquired pneumonia. N Engl J Med 336, , doi: /nejm (1997). 6 McNally, M., Curtain, J., O'Brien, K. K., Dimitrov, B. D. & Fahey, T. Validity of British Thoracic Society guidance (the CRB-65 rule) for predicting the severity of pneumonia in general practice: systematic review and meta-analysis. The British journal of general practice : the journal of the Royal College of General Practitioners 60, e , doi: /bjgp10x (2010). 7 Welker, J. A., Huston, M. & McCue, J. D. Antibiotic timing and errors in diagnosing pneumonia. Arch Intern Med 168, , doi:168/4/351 [pii] /archinternmed (2008).
5 8 Coburn, B., Morris, A. M., Tomlinson, G. & Detsky, A. S. Does this adult patient with suspected bacteremia require blood cultures? JAMA 308, , doi: /jama (2012). 9 Bartlett, J. G. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin Infect Dis 47 Suppl 3, S , doi: / (2008). 10 Mandell, L. A., Marrie, T. J., Grossman, R. F., Chow, A. W. & Hyland, R. H. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis 31, , doi:cid [pii] / (2000). 11 Woodhead, M. et al. Guidelines for the management of adult lower respiratory tract infections--summary. Clin Microbiol Infect 17 Suppl 6, 1-24, doi: /j x (2011). 12 Gleason, P. P., Meehan, T. P., Fine, J. M., Galusha, D. H. & Fine, M. J. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159, (1999). 13 Mills, G. D., Oehley, M. R. & Arrol, B. Effectiveness of beta lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis. BMJ 330, 456, doi:bmj [pii] /bmj (2005). 14 Shefet, D., Robenshtok, E., Paul, M. & Leibovici, L. Empirical atypical coverage for inpatients with community-acquired pneumonia: systematic review of randomized controlled trials. Arch Intern Med 165, , doi:165/17/1992 [pii] /archinte (2005). 15 Maimon, N., Nopmaneejumruslers, C. & Marras, T. K. Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis. Eur Respir J 31, , doi: [pii] / (2008). 16 Public Health Ontario. The Epidemiology of Legionellosis in Ontario, 2012). 17 Pepin, J. et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41, , doi: / (2005). 18 Ray, W. A., Murray, K. T., Hall, K., Arbogast, P. G. & Stein, C. M. Azithromycin and the risk of cardiovascular death. N Engl J Med 366, , doi: /nejmoa (2012). 19 El Solh, A. A., Akinnusi, M. E., Alfarah, Z. & Patel, A. Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia. J Am Geriatr Soc 57, , doi: /j x (2009). 20 Ewig, S. et al. Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax 67, , doi: /thoraxjnl (2012). 21 Ma, H. M., Lee Shun Wah, J. & Woo, J. Should Nursing Home-Acquired Pneumonia Be Treated as Nosocomial Pneumonia? J Am Med Dir Assoc, doi: /j.jamda (2012).
Antimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationKAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA
KAISER PERMANENTE OHIO COMMUNITY ACQUIRED PNEUMONIA Methodology: Expert opinion Issue Date: 8-97 Champion: Pulmonary Medicine Most Recent Update: 6-08, 7-10, 7-12 Key Stakeholders: Pulmonary Medicine,
More informationCommunity-Acquired Pneumonia OBSOLETE 2
Community-Acquired Pneumonia OBSOLETE 2 Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate
More informationTo develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.
Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment
More informationPneumonia Severity Scores:
Pneumonia Severity Scores: Are they Accurate Predictors of Mortality? JILL McEWEN, MD FRCPC Clinical Professor Department of Emergency Medicine University of British Columbia Vancouver, BC Canada President,
More informationJCP Online First, published on June 17, 2013 as /jclinpath Original article
JCP Online First, published on June 17, 2013 as 10.1136/jclinpath-2012-201209 Original article Diagnostic, therapeutic and economic consequences of a positive urinary antigen test for Legionella spp. in
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationCare Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience
More informationCommunity Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium
Community Acquired Pneumonia Background & Rationale to North American Guidelines Lionel Mandell MD FRCPC Brussels Belgium Consider Impact of the disease Issues to reflect upon Impact of the Disease 3-4
More informationCharles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center
Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Kathy Peters is a 63 y.o. patient that presents to your urgent care office today with a history
More informationRepeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia
ORIGINAL ARTICLE Repeated Pneumonia Severity Index Measurement After Admission Increases its Predictive Value for Mortality in Severe Community-acquired Pneumonia Chiung-Zuei Chen, 1 Po-Sheng Fan, 2 Chien-Chung
More informationEpidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell
LOWER RESPIRATORY TRACT INFECTIONS Preface Thomas M. File, Jr xiii Community-Acquired Pneumonia: Pathophysiology and Host Factors with Focus on Possible New Approaches to Management of Lower Respiratory
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form
Last Updated: Version 3.2 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Set Measure ID #: Measure Information Form Performance Measure Name: Pneumococcal Vaccination
More informationGuideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation
Guideline for the Management of Fever Neutropenia in Children with Cancer /or Undergoing Hematopoietic Stem-Cell Transplantation COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive
More informationWORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation
Practical Pointers pointers For for Your your Practice practice The Multiple Facets of CAP Dr. George Fox, MD, MSc, FRCPC, FCCP Community acquired pneumonia (CAP) continues to be a significant health burden
More informationCARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated
More informationThe McMaster at night Pediatric Curriculum
The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives
More informationUsefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia
International Journal of Antimicrobial Agents 31 (2008) 3 11 Review Usefulness of aetiological tests for guiding antibiotic therapy in community-acquired pneumonia K. Strålin Department of Infectious Diseases,
More informationK L Buising, K A Thursky, J F Black, L MacGregor, A C Street, M P Kennedy, G V Brown...
419 RESPIRATORY INFECTION A prospective comparison of severity scores for identifying patients with severe community acquired pneumonia: reconsidering what is meant by severe pneumonia K L Buising, K A
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form
Last Updated: Version 3.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Pneumonia (PN) Set Measure ID #: Measure Information Form Performance Measure Name: Pneumococcal Vaccination
More informationImportance of Atypical Pathogens of Community-Acquired Pneumonia
S35 Importance of Atypical Pathogens of Community-Acquired Pneumonia Joseph F. Plouffe Departments of Internal Medicine and Medical Microbiology and Immunology, Ohio State University College of Medicine,
More informationUPDATE IN HOSPITAL MEDICINE
UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some
More informationLower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone
Eur J Clin Microbiol Infect Dis (2005) 24: 190 195 DOI 10.1007/s10096-005-1295-9 ARTICLE E. García Vázquez J. Mensa J. A. Martínez M. A. Marcos J. Puig M. Ortega A. Torres Lower mortality among patients
More informationRespiratory Infections
Respiratory Infections NISHANT PRASAD, MD THE DR. JAMES J. RAHAL, JR. DIVISION OF INFECTIOUS DISEASES NEWYORK-PRESBYTERIAN QUEENS Disclosures Stockholder: Contrafect Corp., Bristol-Myers Squibb Co Research
More informationBrice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine
Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important
More informationMædica - a Journal of Clinical Medicine
Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS Mortality Risk and Etiologic Spectrum of Community-acquired Pneumonia in Hospitalized Adult Patients Cornelia TUDOSE, Assistant Professor of Pneumology;
More informationThorax Online First, published on May 20, 2008 as /thx
Thorax Online First, published on May 20, 2008 as 10.1136/thx.2008.095562 Systolic Blood Pressure is Superior to Other Haemodynamic Predictors of Outcome in Community Acquired Pneumonia James D Chalmers
More informationUpdate in Hospital Medicine. Update in Hospital Medicine 2009
2009 Bradley A. Sharpe, MD UCSF Division of Hospital Medicine PE in Acute COPD Exacerbations Question: What is the prevalence of PE in patients with COPD who need hospitalization? Design: Systematic review,
More informationPneumococcal pneumonia
Pneumococcal pneumonia Wei Shen Lim Consultant Respiratory Physician & Honorary Professor of Medicine Nottingham University Hospitals NHS Trust University of Nottingham Declarations of interest Unrestricted
More informationChest radiography in patients suspected of pneumonia in primary care: diagnostic yield, and consequences for patient management
Chest radiography in patients suspected of pneumonia in primary care: diagnostic yield, and consequences for patient management 4 Speets AM, Hoes AW, Van der Graaf Y, Kalmijn S, Sachs APE, Mali WPThM.
More informationPolmoniti: Steroidi sì, no, quando. Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma
Polmoniti: Steroidi sì, no, quando Alfredo Chetta Clinica Pneumologica Università degli Studi di Parma Number of patients Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive
More informationMaking the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?
Making the Right Call With Community-Acquired Pneumonia In this article: By Thomas J. Marrie, MD The case of Allyson Allyson, 32, presented to the emergency department with a 48-hour history of anorexia,
More informationGuidelines. 14 Nov Marc Bonten
Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.
More informationMICROBIOLOGICAL TESTING IN PICU
MICROBIOLOGICAL TESTING IN PICU This is a guideline for the taking of microbiological samples in PICU to diagnose or exclude infection. The diagnosis of infection requires: Ruling out non-infectious causes
More informationCharles Feldman. Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand
Opportunistic Infections Community Acquired Pneumonia Charles Feldman Professor of Pulmonology and Chief Physician Charlotte Maxeke Johannesburg Academic Hospital University of the Witwatersrand Introduction
More informationCommunity Acquired Pneumonia
April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of
More informationFraser Health pandemic preparedness
Fraser Health pandemic preparedness DRAFT Last revised: April 2006 General Management of Patients in Acute Care Facilities During an Influenza Pandemic 1. OVERVIEW GENERAL MANAGEMENT OF PATIENTS IN ACUTE
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationCommunity Acquired Pneumonia: Measures to Improve Management and Healthcare Quality
Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality Gonzalo Bearman MD, MPH Assistant Professor of Internal Medicine Divisions of Quality Health Care & Infectious Diseases
More informationOPAT FOR INFECTION IN BRONCHIECTASIS
OPAT FOR INFECTION IN BRONCHIECTASIS AN AUDIT EVALUATING THE USAGE OF OUTPATIENT ANTIBIOTIC THERAPY FOR INFECTIVE EXACERBATIONS OF BRONCHIECTASIS AGAINST CURRENT BRITISH THORACIC SOCIETY GUIDELINES Dr
More informationAntibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults
International Journal of Infectious Diseases (2005) 9, 274 279 http://intl.elsevierhealth.com/journals/ijid Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract
More informationA Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU*
CHEST Original Research A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU* Marcos I. Restrepo, MD, MSc, FCCP; Eric M. Mortensen, MD, MSc; Jose A. Velez, MD;
More informationUpper...and Lower Respiratory Tract Infections
Upper...and Lower Respiratory Tract Infections Robin Jump, MD, PhD Cleveland Geriatric Research Education and Clinical Center (GRECC) Louis Stokes Cleveland VA Medical Center Case Western Reserve University
More informationThe Importance of Appropriate Treatment of Chronic Bronchitis
...CLINICIAN INTERVIEW... The Importance of Appropriate Treatment of Chronic Bronchitis An interview with Antonio Anzueto, MD, Associate Professor of Medicine, University of Texas Health Science Center,
More informationPredictors of Outcomes of Community Acquired Pneumonia in Egyptian Older Adults
Original Contribution/Clinical Investigation Predictors of Outcomes of Community Acquired Pneumonia in Egyptian Older Adults Hossameldin M. M. Abdelrahman Amal E. E. Elawam Ain Shams University, Faculty
More informationGuidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR)
RECOMMENDATIONS OF THE SPANISH SOCIETY OF PULMONOLOGY AND THORACIC SURGERY (SEPAR) Guidelines for the Diagnosis and Treatment of Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic
More informationCommunity acquired pneumonia due to Legionella pneumophila in a tertiary care hospital
101 Research article Community acquired pneumonia due to Legionella pneumophila in a tertiary care hospital Abstract BN Dissanayake 1,, DE Jayawardena 2, CG Senevirathna 1, TM Gamage 1 Sri Lankan Journal
More informationDisclosures. Case 1. Acute Bronchitis. Acute Bronchitis. Community-Acquired Pneumonia and other Respiratory Tract Infections. What do you recommend?
Community-Acquired Pneumonia and other Respiratory Tract Infections none Disclosures Joel T. Katz, M.D. Associate Professor of Medicine Division of Infectious Diseases Brigham and Women s Hospital Case
More informationMarch 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments
March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE
More informationFamily Medicine Clinical Pharmacy Forum Vol. 3, Issue 1 (January/February 2007)
1 Family Medicine Clinical Pharmacy Forum Vol. 3, Issue 1 (January/February 2007) Family Medicine Clinical Pharmacy Forum is a brief bi-monthly publication from the Family Medicine clinical pharmacists
More informationCommunity-acquired pneumonia in adults
Prim Care Clin Office Pract 30 (2003) 155 171 Community-acquired pneumonia in adults Julio A. Ramirez, MD a,b, * a Department of Medicine, University of Louisville School of Medicine, 512 S. Hancock Street,
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationPneumonia 2017 OMAR PIRZADA
Pneumonia 2017 OMAR PIRZADA Pneumonia Pneumonia is common 0.5-1% of adults per year, 5-12% presenting to GP with LRTi 22-42% will be admitted to hospital Symptoms and signs Case 1 26 year old man Sudden
More informationPneumonia in the Hospitalized
Pneumonia in the Hospitalized Patient: Use of Steroids Nicolette Myers, MD Pulmonary/Sleep/Critical Care November 9, 2018 Park Nicollet Clinic Facts About Pneumonia CAP is the 8 th most common cause of
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationPneumonia. Dr. Rami M Adil Al-Hayali Assistant professor in medicine
Pneumonia Dr. Rami M Adil Al-Hayali Assistant professor in medicine Definition Pneumonia is an acute respiratory illness caused by an infection of the lung parenchyma, associated with recently developed
More informationEarly mortality in patients with communityacquired pneumonia: causes and risk factors
Eur Respir J 2008; 32: 733 739 DOI: 10.1183/09031936.00128107 CopyrightßERS Journals Ltd 2008 Early mortality in patients with communityacquired : causes and risk factors C. Garcia-Vidal*, N. Fernández-Sabé*,
More informationPatterns of Resolution of Chest Radiograph Abnormalities in Adults Hospitalized with Severe Community-Acquired Pneumonia
MAJOR ARTICLE Patterns of Resolution of Chest Radiograph Abnormalities in Adults Hospitalized with Severe Community-Acquired Pneumonia Anke H. W. Bruns, 1 Jan Jelrik Oosterheert, 1 Mathias Prokop, 2 Jan-Willem
More informationPreventing and Treating Community-Acquired Pneumonia
PL Detail-Document #310618 This PL Detail-Document gives subscribers additional insight related to the Recommendations published in PHARMACIST S LETTER / PRESCRIBER S LETTER June 2015 Preventing and Treating
More information3.5. Background - CAP. Disclosure. Goal. Why Guidelines
Disclosure The New PIDS-IDSA Community Acquired Pneumonia Guidelines Ricardo Quiñonez, MD, FAAP, FHM Section of Pediatric Hospital Medicine Baylor College of Medicine Texas Children s Hospital I have no
More informationCommunity-Acquired Pneumonia. Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital. Nothing to disclose.
Community-Acquired Pneumonia Lisa G. Winston, MD University of California, San Francisco San Francisco General Hospital Nothing to disclose. Community-Acquired Pneumonia Talk will focus on adults Guideline
More informationAcute Respiratory Infection. Dr Anthony Gibson
Acute Respiratory Infection Dr Anthony Gibson Range of Conditions Upper tract Common Cold coryza Sore Throat- Pharyngitis Sinusitis Epiglottitis Range of Conditions Lower Acute Bronchitis Acute Exacerbation
More informationPatient information: Pneumonia in adults (Beyond the Basics)
Page 1 of 8 Official reprint from UpToDate www.uptodate.com 2014 UpToDate Patient information: Pneumonia in adults (Beyond the Basics) Authors Thomas J Marrie, MD Thomas M File, Jr, MD Section Editor John
More informationMANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION
MANAGEMENT OF COMMUNITY ACQUIRED PNEUMONIA IN THE ASIA PACIFIC REGION Chong-Kin LIAM Department of Medicine Faculty of Medicine University of Malaya Kuala Lumpur liamck@ummc.edu.my COMMUNITY ACQUIRED PNEUMONIA
More informationHigh-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia
High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia Review Andrew F. Shorr, MD, MPH, FCCP Department of Medicine Pulmonary and Critical Care Medicine, Washington Hospital Center, Washington,
More informationFever in neonates (age 0 to 28 days)
Fever in neonates (age 0 to 28 days) INCLUSION CRITERIA Infant 28 days of life Temperature 38 C (100.4 F) by any route/parental report EXCLUSION CRITERIA Infants with RSV Febrile Infant 28 days old Ill
More informationI n the assessment and management of community acquired
377 RESPIRATORY INFECTION Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study W S Lim, M M van der Eerden, R Laing, W G Boersma,
More informationCommunity acquired pneumonia
Community acquired pneumonia definition Symptoms of an acute LRTI New focal signs on chest examination At least one systemic feature New radiographic shadow Defination{Crofton} IT IS A SYNDROME CAUSED
More informationSetting The setting was secondary care. The economic study was carried out in the USA.
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia Paladino J A, Gudgel L D, Forrest A, Niederman
More informationClinical failure, community-acquired pneumonia, management, outcome, prognosis, risk-factors
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01535.x Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia M. Hoogewerf 1, J. J. Oosterheert 1, E. Hak 2, I. M.
More informationCurrent and Emerging Legionella Diagnostics
Current and Emerging Legionella Diagnostics Nicole Wolter Centre for Respiratory Diseases and Meningitis (CRDM) National Institute for Communicable Diseases nicolew@nicd.ac.za 7 th FIDSSA Conference, Cape
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationInfectious disease specialists are grappling with
A FOCUS ON COMMUNITY-ACQUIRED PNEUMONIA * Richard P. Wenzel, MD, MSc ABSTRACT Community-acquired pneumonia (CAP) is becoming a more prominent health problem in the United States, in part because of the
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationBlood cultures in ED. Dr Sebastian Chang MBBS FACEM
Blood cultures in ED Dr Sebastian Chang MBBS FACEM Why do we care about blood cultures? blood cultures are the most direct method for detecting bacteraemia in patients a positive blood culture: 1. can
More informationProspective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital
Prospective audit and feedback of piperacillin-tazobactam use in a 1115 bed acute care hospital Final Results Nathan Beahm, BSP, PharmD(student) September 10, 2016 Objectives Review background information
More informationGetting Smart About: Upper Respiratory Infections
Getting Smart About: Upper Respiratory Infections Daniel Z. Uslan, MD Assistant Clinical Professor Director, Antimicrobial Stewardship Program UCLA Health System Disclosures None relevant to the topic
More informationAndrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015
The TIMES Project: (Time to Initiation of Antibiotic Therapy in Medical Patients Presenting to the Emergency Department with Sepsis) - Preliminary Findings Andrea Blotsky MDCM FRCPC General Internal Medicine,
More informationMicrobial aetiology of community-acquired pneumonia and its relation to severity
< Additional data are published online only. To view these files please visit the journal online (http://thorax.bmj.com). 1 Servei de Pneumologia, Institut del Tòrax, Hospital Clinic, IDIBAPS, Universitat
More informationThe IDSA/ATS consensus guidelines on the management of CAP in adults
The IDSA/ATS consensus guidelines on the management of CAP in adults F. Piffer F. Tardini R. Cosentini U.O. Medicina d'urgenza, Gruppo NIV, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina
More informationRespiratory Multiplex Array. Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract
Rapid, simultaneous detection of 22 bacterial and viral pathogens of the upper and lower respiratory tract Rapid, simultaneous detection of 22 bacterial and viral pathogens within the upper and lower respiratory
More informationHow do we define pneumonia?
Robert L. Keith MD FCCP Associate Professor of Medicine Division of Pulmonary Sciences & Critical Care Medicine Denver VA Medical Center University of Colorado Denver How do we define pneumonia? Fever
More informationEfficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis
Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis Vallières, E., Tumelty, K., Tunney, M. M., Hannah, R., Hewitt, O., Elborn, J. S., & Downey, D. G. (2017). Efficacy of Pseudomonas
More informationBradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF -- William Osler, M.D.
Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu a. An ailment that often leads to suffocation and death. b. A friend of the aged. c. A common
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 25, 2018 0800 EDT NH-HAN 20180825 Cluster of Legionella pneumophila Pneumonia (Legionnaire
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationPOEMS Patient Oriented Evidence that Matters
Patient Oriented Evidence that Matters Melatonin effective for some sleep disorders Buscemi N, Vandermeer B, Hooton PR, et al. Melatonin for treatment of sleep disorders. Evidence Report/Technology Assessment
More informationSeverity prediction rules in community acquired pneumonia: a validation study
Thorax 2000;55:219223 219 Severity prediction rules in community acquired pneumonia: a validation study W S Lim, S Lewis, J T Macfarlane Respiratory Medicine, City Hospital, Nottingham NG5 1PB, UK W S
More informationCommunity acquired pneumonia (CAP) is defined as an acute infection of pulmonary
Focused Issue of This Month Diagnosis of CommunityAcquired Pneumonia Ki Suck Jung, MD Department of Internal Medicine, Hallym University College of Medicine Email : pulmoks@hallym.ac.kr J Korean Med Assoc
More informationGuidelines/Guidance/CAP/ Hospitalized Child. PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014
Guidelines/Guidance/CAP/ Hospitalized Child PHM Boot Camp 2014 Jay Tureen, MD June 19, 2014 CAP in Children: Epi Greatest cause of death in children worldwide Estimated > 2 M deaths in children In developed
More informationCommunity-Acquired Bacterial Pneumonia: Is There Anything New? Steve Vacalis DO CaroMont Health Regional Medical Center Gastonia, North Carolina
Community-Acquired Bacterial Pneumonia: Is There Anything New? Steve Vacalis DO CaroMont Health Regional Medical Center Gastonia, North Carolina This presentation is sponsored by: and supported by an educational
More informationPNEUMONIA IN CHILDREN. IAP UG Teaching slides
PNEUMONIA IN CHILDREN 1 INTRODUCTION 156 million new episodes / yr. worldwide 151 million episodes developing world 95% in developing countries 19% of all deaths in children
More informationPOLICY FOR TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS
POLICY F TREATMENT OF LOWER RESPIRATY TRACT INFECTIONS Written by: Dr M Milupi, Consultant Microbiologist Date: June 2018 Approved by: The Drugs & Therapeutics Committee Date: July 2018 Implementation
More informationPneumococcal Pneumonia: Update on Therapy in the Era of Antibiotic Resistance
a of Antibiotic Resistance March 01, 2003 By Bernard Karnath, MD [1], Akua Agyeman, MD [2], and Albert Lai, MD [3] Sir William Osler once called pneumococcal pneumonia the captain of the men of death.
More informationPROGNOSTIC ASSESSMENT IN COMMUNITY ACQUIRED PNEUMONIA
From the Department of Medicine, Division of Infectious Diseases Karolinska University Hospital Karolinska Institutet, Stockholm, Sweden PROGNOSTIC ASSESSMENT IN COMMUNITY ACQUIRED PNEUMONIA Richard Dwyer
More informationAntimicrobial Stewardship and Urinary Tract Infections
Antimicrobial Stewardship and Urinary Tract Infections Samantha Loutzeheiser, PharmD, BCPS Andrea Pallotta, PharmD, BCPS (AQ-ID), AAHIVP Cleveland Clinic Medina Hospital Cleveland Clinic Main Campus Objectives
More informationEDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE
EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click
More informationPNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT
Dr Marie Bruyneel and Deborah Konopnicki BVIKM/SBMIC November 8th, 2012 PNEUMONIA IN A PRESUMED IMMUNOCOMPETENT PATIENT Men, 54 years Emergency room on end october 2009 Sent by his family doctor for Influenza
More informationElements for a Public Summary
VI.2 VI.2.1 Elements for a Public Summary Overview of disease epidemiology Rapenin (phenoxymethylpenicillin potassium) is indicated for the treatment of infections caused by penicillin-sensitive bacteria.
More information